Cargando…
Unearthing new genomic markers of drug response by improved measurement of discriminative power
BACKGROUND: Oncology drugs are only effective in a small proportion of cancer patients. Our current ability to identify these responsive patients before treatment is still poor in most cases. Thus, there is a pressing need to discover response markers for marketed and research oncology drugs. Screen...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801688/ https://www.ncbi.nlm.nih.gov/pubmed/29409485 http://dx.doi.org/10.1186/s12920-018-0336-z |